Class I and II HLA antibodies in pediatric patients with thalassemia major.

about

Class I and II HLA antibodies in pediatric patients with thalassemia major.

Item

http://www.wikidata.org/entity/Q38932133

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Class I and II HLA antibodies in pediatric patients with thalassemia major.

@en

type

Item

label

Class I and II HLA antibodies in pediatric patients with thalassemia major.

@en

prefLabel

Class I and II HLA antibodies in pediatric patients with thalassemia major.

@en

P1476

Class I and II HLA antibodies in pediatric patients with thalassemia major.

@en

P2093

Alan R Anderson

http://www.w3.org/2001/XMLSchema#string

Ankoor Shah

http://www.w3.org/2001/XMLSchema#string

Cassandra D Josephson

http://www.w3.org/2001/XMLSchema#string

Howard M Gebel

http://www.w3.org/2001/XMLSchema#string

Jeanne Boudreaux

http://www.w3.org/2001/XMLSchema#string

Marianne E McPherson Yee

http://www.w3.org/2001/XMLSchema#string

Robert A Bray

http://www.w3.org/2001/XMLSchema#string

P2860

Desensitization for solid organ and hematopoietic stem cell transplantation

HLA antibody detection with solid phase assays: great expectations or expectations too great?

The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure

Prevalence of Alloimmunization to Human Platelet Antigen Glycoproteins and Human Leucocyte Antigen Class I in β Thalassemia Major Patients in Western India

The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children.

A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation.

High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

The role of donor-specific HLA alloantibodies in liver transplantation.

Clinical relevance of pretransplant HLA class II donor-specific antibodies in renal transplantation patients with negative T-cell cytotoxicity crossmatches.

Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.

P304

878-884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.13440

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26666394

http://www.w3.org/2001/XMLSchema#string